Literature DB >> 16131610

Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height.

C Traggiai, P Polo Perucchin, K Zerbini, R Gastaldi, P De Biasio, R Lorini.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16131610     DOI： 10.1530/eje.1.01975

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


× No keyword cloud information.
  15 in total

1.  EFFECTS OF THE GONADOTROPIN-RELEASING HORMONE AGONIST THERAPY ON GROWTH AND BODY MASS INDEX IN GIRLS WITH IDIOPATHIC CENTRAL PRECOCIOUS PUBERTY.

Authors:  Z Donbaloğlu; A Bedel; E Barsal Çetiner; B Singin; B Aydın Behram; H Tuhan; M Parlak
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Apr-Jun       Impact factor: 1.104

2.  Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls.

Authors:  Kobra Shiasi Arani; Fatemeh Heidari
Journal:  Int J Endocrinol Metab       Date:  2015-07-01

3.  Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone.

Authors:  Mo Kyung Jung; Kyung Chul Song; Ah Reum Kwon; Hyun Wook Chae; Duk Hee Kim; Ho-Seong Kim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-12-31

4.  Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty.

Authors:  Ahmet Anık; Gönül Çatlı; Ayhan Abacı; Ece Böber
Journal:  Indian J Endocrinol Metab       Date:  2015 Mar-Apr

5.  The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty.

Authors:  Jong Wan Yoon; Hyun A Park; Jieun Lee; Jae Hyun Kim
Journal:  Korean J Pediatr       Date:  2017-12-22

6.  The different effects of gonadotropin-releasing hormone agonist therapy on body mass index and growth between normal-weight and overweight girls with central precocious puberty.

Authors:  Won Jun Yang; Keun Hyeok Ko; Kon Hee Lee; Il Tae Hwang; Yeon Joung Oh
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-03-31

Review 7.  Pros and cons of GnRHa treatment for early puberty in girls.

Authors:  Ruben H Willemsen; Daniela Elleri; Rachel M Williams; Ken K Ong; David B Dunger
Journal:  Nat Rev Endocrinol       Date:  2014-04-08       Impact factor: 43.330

8.  Higher prevalence of obesity and overweight without an adverse metabolic profile in girls with central precocious puberty compared to girls with early puberty, regardless of GnRH analogue treatment.

Authors:  Ana Colmenares; Peter Gunczler; Roberto Lanes
Journal:  Int J Pediatr Endocrinol       Date:  2014-04-17

9.  Body mass index in girls with idiopathic central precocious puberty during and after treatment with GnRH analogues.

Authors:  A J Arcari; M G Gryngarten; A V Freire; M G Ballerini; M G Ropelato; I Bergadá; M E Escobar
Journal:  Int J Pediatr Endocrinol       Date:  2016-08-05

10.  Longitudinal follow-up to near final height of auxological changes in girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analog and grouped by pretreatment body mass index level.

Authors:  Jongho Park; Tae Ho Hwang; Yong-Dae Kim; Heon-Seok Han
Journal:  Ann Pediatr Endocrinol Metab       Date:  2018-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.